Point72 Asset Management, L.P. 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:54 pm Sale | 2024-09-30 | 13G | Sutro Biopharma, Inc. STRO | Point72 Asset Management, L.P. | 2,997,453 3.700% | -2,935,455 (-49.48%) | Filing |
| 2024-04-05 4:05 pm Purchase | 2024-04-04 | 13G | Sutro Biopharma, Inc. STRO | Point72 Asset Management, L.P. | 5,932,908 7.900% | 5,932,908 (New Position) | Filing |